<DOC>
	<DOCNO>NCT00506324</DOCNO>
	<brief_summary>This project define effect swallow intensity modulation radiotherapy organ preservation treatment involve chemoradiation 125 oral , laryngeal , pharyngeal cancer patient previously untreated Stage III IV disease identify optimum treatment strategy . The specific aim : 1 ) define physiologic effect chemoradiotherapy IMRT various site upper aerodigestive/vocal tract include cervical esophagus rate patient return oral intake ; 2 ) document acute toxicity , late complication , locoregional failure survival , relationship fibrosis rating measure laryngeal elevation ; 3 ) determine whether patient 's swallow mechanism compensate physiologic deficit swallow introduction intervention ( postural change , voluntary swallow maneuver , several bolus volume ) ; 4 ) determine whether time return oral intake , effect swallow maneuver and/or volume , presence esophageal stricture duration success dilatation depend radiation dose volume specific structure head neck ; 5 ) define relationship tongue base pressure development esophageal stricture . Patients accrued Northwestern University University Chicago . Effects define term swallow function , morbidity , toxicity survival . Other outcome measure maintenance voluntary control ( flexibility ) oropharyngeal region indicate ability correctly produce swallow maneuver ; positive change cricopharyngeal open duration normal bolus volume shift . Patients studied pretreatment , 1 month , 3 month , 6 month , 12 month , 24 month post completion chemoradiation . At assessment , patient receive videofluoroscopic assessment swallow utilizing standard protocol , assessment xerostomia , mucositis , fibrosis well assessment disease status quality life scale . Head neck cancer severe problem affect public health . Most current treatment combination radiotherapy chemotherapy , result severe swallow problem may make patient unwilling accept type treatment . This project attempt quantify swallow problem associate specific treatment effect intervention swallow problem .</brief_summary>
	<brief_title>Oropharyngeal Function After Radiotherapy With IMRT</brief_title>
	<detailed_description>A . Subjects One hundred twenty-five patient disease Stages III IV squamous cell cancer oral cavity , larynx pharynx serve subject . B . Intensity Modulation Radiotherapy Guidelines Anatomical data require planning process acquire use Philip 's AcQSim CT simulation system . The immobilized patient square relative bore Picker PQ2000S CT scanner use ceiling side laser system . A scout view obtain superior inferior border volume study determine . Forty second prior commencement image data acquisition contrast medium ( 125 cc Ultravist 300 ) power inject rate 1.3-2.0 cc/sec use Liebel-Flarsheim device . The CT data set acquire 3 mm slice thickness space use spiral mode scanner . While patient table , image transfer VoxelQ work station run AcQSim software version 4.1.1 . Before patient release reference isocenter establish record AcQSim system mark face mask use isocenter locate laser CT simulator , already indicate radio-opaque fiducials . The physician outline target volume , GTVs CTVs , per ICRU 50 guideline outline critical structure brain stem , spinal cord , salivary gland , optic apparatus , etc . After do , image structure data transfer either two treatment planning work station : NOMOS Corvus system run software version 5.0 ADAC Pinnacle RTP system run software version 6.2b . A planning target margin ( PTV ) add take account organ motion setup uncertainty . Lateral Anterior-Posterior digitally reconstruct radiograph ( DRRs ) demonstrate location isocenter produce AcQSim system correct patient positioning confirm prior commencement treatment . The prescription target ( ) define dose goal treatment , minimal acceptable dose percent volume dose maximum acceptable dose . The prescription radio sensitive structure set nominally allow dose , percent volume overdose , maximum tolerable dose minimum dose radiation damage observe . These specification , various target critical structure , translate defining three point dose volume histogram ( DVH ) curve tissue type . The Corvus system compute optimal beam intensity map use simulated anneal algorithm whereas ADAC system use sequential quadratic search method minimize quadratic objective function , construct set dose-based dose-volume-based objective individual region interest . Delivery dose prescribed idealized map accomplish use step shoot IMRT institution . In method beam direction incident patient along field size collimator angle determine treatment planner software design IMRT intensity map . Therefore important choose beam geometry carefully maximize exposure target minimize exposure critical structure visualize beam 's eye view . The IMRT beam create utilizing standard 80 cm leaf MLC Elekta Sli linear accelerator . Radiotherapy Guidelines propose study : 1 . All patient immobilization device treatment planning base Computerized Tomography ( CT ) information treatment position . The CT slice thickness target 3mm . 2 . CT Magnetic Resonance Imaging ( MRI ) data use define various target contour normal structure . MRI information use indicate . Image fusion use relate CT/MRI data necessary . 3 . The field size arrangement discretion attend Radiation Oncologist . ICRU 50 guideline use various Tumor Target Nomenclature : 1 . The Gross Tumor Volume ( GTV ) : All gross disease determine clinical examination radiographic study . 2 . The Clinical Target Volume ( CTV ) : The area potentially contain microscopic disease . Lymph node group risk microscopic disease outline part correspond CTV . The margin GTV correspond CTV vary 0.2cm 2.5cm depend upon proximity critical uninvolved structure . 3 . The Planning Target Volume ( PTV ) : Provides margin around CTV compensate internal motion set error . Typically 5mm margin may use around CTV . Radiation Targets Dose Specifications : The follow definition target . The radiation dose deliver specified protocol : 1 . Primary Target Volume ( PTV1 ) : Includes gross tumor volume volume encompass lymph node moderate high risk metastasis ( first echelon node ) lymph node low risk metastatic disease correspond CTVs . 2 . Secondary Target Volume ( PTV2 ) : Includes gross tumor volume volume encompass lymph node moderate high potential risk metastasis correspond CTVs . 3 . Tertiary Target Volume ( PTV3 ) : Includes gross tumor volume primary tumor nodal metastases correspond CTVs . Low Neck : The midjugular , low jugular , supraclavicular node treat either IMRT alternatively AP field beam split IMRT field . This discretion treat physician . If IMRT approach use , necessary submit DVHs PTV . However , IMRT approach use , necessary generate DVHs PTV . Radiation dose attach protocol . Neck Nodes : Guidelines anatomic boundary CT-based delineation neck node per consensus Atlas RTOG website ( www.RTOG.org → Researcher → H/N Atlas ) . Normal Tissues : The appropriate normal organ contour . Dose Volume Histograms ( DVH ) generate . An attempt make keep maximum radiation dos follow organ follow ; since radiation structure low fraction per day maximum dose partial volume , believe acceptable dose level . Brain Stem : 54 Gy Optic Nerve/Chiasm : 55 Gy Spinal Cord : 45 Gy Mandible/TM Joint : 70 Gy 1cc PTV exceed 75 Gy Larynx 70 Gy Parotid Glands : Attempt achieve mean dose 26 Gy least one gland least 20cc combined volume parotid gland receive 20 Gy least 50 % gland receive 30 Gy ( achieve least one gland ) . Toxicity Reporting : 1 . For acute toxicity NCI/CTCAE Version 3.0 use . 2 . For late toxicity , RTOG/EORTC late toxicity criterion use . Each treatment judge compliant Image guide therapy Center St. Louis guideline : 1 . No variation ( Total Coverage ) : Coverage specify Radiation Guideline Section . 2 . Minor variation ( Marginal Coverage ) : The 93 % isodose cover 95 % 98 % appropriate PTV volume overdose exceed specify Radiation Guideline Section 5 % PTV volume . 3 . Major variation ( Miss ) : The 93 % isodose surface cover less 95 % appropriate PTV overdose region appropriate PTV great 5 % PTV volume . C. Data Collection Schedule Functional data collect patient 6 point time : pretreatment 5 time completion chemoradiation -- 1 month , 3 month , 6 month , 12 month , 24 month . 1 . Swallow Evaluation . At evaluation point , patient receive maximum 33 swallow study videofluoroscopy concurrent manometry . A 3 mm flexible catheter contain 2 solid state pressure sensor 3 cm apart position transnasally begin study , one sensor locate base tongue second sensor top upper esophageal sphincter . This protocol allow measurement pressure generate tongue base . The concurrent manometry allow u directly measure pharyngeal pressure swallow . All swallow view lateral plane except last three 3 ml swallow view A-P plane . Subjects require swallow volume viscosity manage comfortably . All difficulty record data sheet . Videofluoroscopy Protocol ( 3 swallow combination ) : 1 ml thin liquid barium 3 ml thin liquid barium 5 ml thin liquid barium 10 ml thin liquid barium 3 ml pudding ¼ Lorna Doone cookie 3 ml barium paste 3 ml thin liquid barium - chin 3 ml thin liquid barium - effortful swallow 3 ml thin liquid barium - super-supraglottic swallow 3 ml thin liquid barium - Mendelsohn maneuver 3 ml thin liquid barium - P-A view 2 . Measure Xerostomia . At radiographic study swallow , patient 's stimulated saliva production quantify take difference weight fold sterile sponge ( 10 x 10 cm Kerlix ) chew 2 minute . 3 . Data Collection Regarding Onset Nature Oral Intake . At 6 swallow data collection point , status nature oral non-oral intake also report , well reason non-oral intake , i.e. , nausea versus swallow disorder . The date patient begin experience difficulty eating , non-oral feeding begin , partial full oral intake begin record report speech-language pathologist . 4 . Ratings Mucositis . Oral mucositis rating complete pretreatment 5 interval treatment . The scale rate ulceration 4-point scale ( 0 = lesion 3 = lesion &gt; 3 cm2 ) erythema 3-point scale ( 0 = none ; 1 = severe ; 2 = severe ) 10 location oral cavity ( upper low lip , right left cheek , right leave ventral lateral tongue , floor mouth , soft palate/fauces hard palate ) . The mucositis rating do participate speech-language pathologist ( SLP ) train use scale . 5 . Patient 's Perception Function . A data form develop define patient 's perception swallowing function , well dry mouth . The patient complete four-page form . 6 . QOL scale : Performance Status Scale Head Neck Cancer ( PSS-HN ) ( List et al. , 1990 ) : This brief 3-part questionnaire give SLP evaluation point ; The M.D . Anderson Dysphagia Inventory ( MDADI ) 20-item self-administered scale investigates impact dysphagia patient 's quality life ; The University Washington Quality Life scale ( UW QOL ) 6 item clinician-administered scale . 7 . Survival Locoregional failure : Patients follow overall survival , relapse free survival locoregional failure . The locoregional failure pattern categorize within ) Primary Target Region ( PTV1 ) ; b ) Secondary Target Region ( PTV2 ) c ) Tertiary Target Region ( PTV3 ) .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>The target population study 125 patient stage III IV squamous cell lesion oral cavity , oropharynx , pharynx larynx , unknown primary . No patient prior treatment head neck cancer otolaryngologic neurologic disorder affect swallow preexist swallow disorder .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Intensity Modulated Radiotherapy</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Head Neck Neoplasms</keyword>
	<keyword>Dysphagia</keyword>
</DOC>